ARTICLE | Top Story
Onyx, Ono in proteasome inhibitor deal
September 9, 2010 12:12 AM UTC
Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) granted Ono Pharmaceutical Co. Ltd. (Tokyo:4528; Osaka:4528) exclusive rights in Japan to develop and commercialize two proteasome inhibitors for cancer. Onyx w...